Patients whose autoimmune disorders such as lupus were initially dismissed by doctors as psychosomatic show long-lasting ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...
Feeling disbelieved when knowing that there is something very wrong with your body can have devastating and long-term ...
An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to ...
Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...
Genentech, a Roche Group company(OTCQX:RHHBY) said on Wednesday that the U.S. FDA accepted the company’s supplemental ...
Diagnosing Alzheimer's disease before people have any symptoms is possible, but brings up concerns when so few treatments are ...
The body aches, fever and tiredness that the flu causes come on one to four days after being exposed to the virus. Ika84 via ...
Acelyrin and Alumis plan to close their merger in the second quarter of 2025, pending clearances and shareholder approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback